Can SAGA Metals Corp. turn a Rio Tinto castoff into Quebec’s next titanium discovery story? (TSXV: SAGA)
What Olaplex Holdings, Inc.’s $2.06-per-share buyout by Henkel AG & Co. KGaA signals for beauty sector consolidation (NASDAQ: OLPX)
What Cadre Holdings, Inc.’s $10.3m acquisition signals about consolidation in tactical gear markets (NYSE: CDRE)
Rhinebeck Bank taps MANTL for omnichannel account opening as Alkami Technology (ALKT) accelerates post-acquisition integration
Read More 6 minute read Pharma Industry News BioCity’s SC0062 secures second breakthrough therapy designation in China for diabetic kidney disease BioCity Biopharma’s ETA-selective SC0062 earns second Breakthrough Therapy Designation in China for diabetic kidney disease, reinforcing its CKD potential. byPallavi MadhirajuJune 26, 2025